Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IEM)

Share Price Information for Impax Asset Management (IEM)

Share Price is delayed by 15 minutes
Get Live Data
460.00    -5.00 (-1.08%)
Bid:
457.00
Ask:
458.00
Spread: 1.00 (0.219%)
Market Cap: £182.35m
IEM Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Flash research note from QuotedData

Today 10:53

RNS Number : 5972H
Impax Environmental Markets PLC
09 June 2026
 

 

Impax Environmental Markets - Flash note from QuotedData

9 June 2026

The endgame?

Impax Environmental Markets (IEM) has produced poor investment performance and is under pressure from activist hedge fund Saba Capital. In May, an exit tender offer saw about 80% of shares tendered. The fund, now much smaller, faces a Requisitioned General Meeting (RGM) on 17 June, where Saba aims to replace the entire IEM board with its own nominees.

IEM's chairman has said that Saba now effectively controls the fund's strategy, making it likely that Saba's proposals will be approved. If so, this will end the current board's tenure and start a new phase for IEM. There is little detail on what changes might follow; Saba has only said that the new board will focus on delivering long-term value for shareholders.

Full Research:

https://quoteddata.com/research/impax-environmental-markets-the-endgame-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Impax Environmental Markets Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSFSUUEMSEIM
Date   Source Headline
11th Feb 202612:27 pmRNSNet Asset Value(s)
10th Feb 202612:09 pmRNSNet Asset Value(s)
10th Feb 202610:16 amRNSHolding(s) in Company
9th Feb 202612:43 pmRNSNet Asset Value(s)
6th Feb 202611:55 amRNSNet Asset Value(s)
5th Feb 202611:57 amRNSNet Asset Value(s)
4th Feb 202612:42 pmRNSNet Asset Value(s)
3rd Feb 20264:28 pmRNSDividend Declaration
3rd Feb 20261:00 pmRNSNet Asset Value(s)
2nd Feb 20265:00 pmRNSHolding(s) in Company
2nd Feb 20264:59 pmRNSHolding(s) in Company
2nd Feb 20261:14 pmRNSNet Asset Value(s)
2nd Feb 20269:53 amRNSTotal Voting Rights
30th Jan 20261:17 pmRNSNet Asset Value(s)
29th Jan 202612:33 pmRNSNet Asset Value(s)
28th Jan 20264:09 pmRNSHolding(s) in Company
28th Jan 20263:05 pmRNSNet Asset Value(s)
27th Jan 202612:14 pmRNSNet Asset Value(s)
26th Jan 20262:27 pmRNSNet Asset Value(s)
26th Jan 20267:00 amRNSPublication of Continuation Tender Offer Circular
23rd Jan 202612:37 pmRNSNet Asset Value(s)
22nd Jan 202612:48 pmRNSNet Asset Value(s)
21st Jan 20262:19 pmRNSNet Asset Value(s)
20th Jan 202612:47 pmRNSNet Asset Value(s)
19th Jan 20261:43 pmRNSNet Asset Value(s)
16th Jan 20262:22 pmRNSNet Asset Value(s)
16th Jan 20267:00 amRNSProposed Tender Offer
15th Jan 20261:30 pmRNSNet Asset Value(s)
14th Jan 202612:51 pmRNSNet Asset Value(s)
13th Jan 20261:40 pmRNSNet Asset Value(s)
12th Jan 202612:55 pmRNSNet Asset Value(s)
9th Jan 20265:01 pmRNSHolding(s) in Company
9th Jan 202611:06 amRNSNet Asset Value(s)
8th Jan 20264:26 pmRNSHolding(s) in Company
8th Jan 20262:04 pmRNSNet Asset Value(s)
7th Jan 20264:29 pmRNSHolding(s) in Company
7th Jan 20262:38 pmRNSNet Asset Value(s)
7th Jan 20269:43 amRNSHolding(s) in Company
6th Jan 20263:41 pmRNSNet Asset Value(s)
5th Jan 20263:09 pmRNSNet Asset Value(s)
5th Jan 202612:45 pmRNSHolding(s) in Company
2nd Jan 202612:49 pmRNSNet Asset Value(s)
2nd Jan 20269:36 amRNSTotal Voting Rights
31st Dec 202512:28 pmRNSNet Asset Value(s)
30th Dec 20251:10 pmRNSNet Asset Value(s)
29th Dec 20251:19 pmRNSNet Asset Value(s)
24th Dec 202512:57 pmRNSNet Asset Value(s)
23rd Dec 202511:25 amRNSNet Asset Value(s)
23rd Dec 20259:27 amRNSHolding(s) in Company
23rd Dec 20259:27 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.